缺血性增殖型脑血管病2例报道及回顾性分析

2018-05-09 李京润 高超 周茜 中国临床神经科学

增殖型脑血管病(cerebralproliferativeangiopathy,CPA)是一种罕见的脑血管病,病例特点是弥漫性增生的畸形血管内混杂正常脑实质。因CPA的临床表现、影像学表现、组织病理等方面均不同于典型脑动静脉畸形,近年来CPA渐被独立研究。CPA临床表现多样,患者可出现癫、头痛、缺血性神经功能障碍、颅内出血等症状。目前国内尚未见有关于CPA的血流动力学研究以及相关治疗策略的研究报道

【病例摘要】

增殖型脑血管病(cerebralproliferativeangiopathy,CPA)是一种罕见的脑血管病,病例特点是弥漫性增生的畸形血管内混杂正常脑实质。因CPA的临床表现、影像学表现、组织病理等方面均不同于典型脑动静脉畸形,近年来CPA渐被独立研究。CPA临床表现多样,患者可出现癫、头痛、缺血性神经功能障碍、颅内出血等症状。目前国内尚未见有关于CPA的血流动力学研究以及相关治疗策略的研究报道。本研究通过对2例经全脑血管造影(DSA)明确诊断的缺血型CPA病例进行回顾性分析,同时复习相关文献进一步探讨其血流动力学特点以及治疗方法等问题,以引起临床医生对这类特殊脑血管疾病的重视。

例1

【一般资料】

患者住院号9700××××,男性,6岁,江苏省人。

【现病史】

患儿因“反复发作一过性头晕伴左上肢乏力1年余,加重1个月”于2015年11月就诊入住复旦大学附属华山医院(我院)神经外科。患儿症状因劳累或哭闹而诱发,休息后缓解,症状反复发作,且进行性加重。病程中无肢体抽搐或意识障碍发作,无黑矇晕厥,无视物模糊等症状。目前生活基本自理,睡眠良好,胃纳可,大小便正常,体重无明显下降。

【体格检查】

入院时患儿一般情况良好,发育正常,营养状况良好,查体配合,对答切题;双侧瞳孔等大等圆,直径2.5mm,对光反应灵敏;无复视,吞咽良好,伸舌居中,双侧额纹、鼻唇沟对称,闭目良好;左侧屈肘、伸肘、屈腕、伸腕肌力4+级,左侧屈髋、伸髋、屈膝、伸膝肌力5-级,四肢肌张力正常,腱反射(+),双侧Babinski征(-)、Hoffmann征(-);躯体感觉、共济检查未见明显异常。实验室检查:①血常规示白细胞10.96×109/L(参考值:4.5~11.0×109/L),红细胞4.79×1012/L(参考值:4.0~5.9×1012/L),血红蛋白134g·L-1(参考值:120~160g·L-1),血小板293×109/L(参考值:100~300×109/L),中性粒细胞49.1%(参考值:45.0%~70.0%);②空腹血糖:葡萄糖4.7mmol·L-1(参考值:3.9~5.8mmol·L-1);③肾功能:肌酐37μmol·L-1(参考值:53~97μmol·L-1);④肝功能:丙氨酸转氨酶13U·L-1(参考值:<38U·L-1),天冬氨酸转氨酶22U·L-1(参考值:<34U·L-1);⑤血电解质:钾4.1mmol·L-1(参考值:3.5~5.5mmol·L-1),钠141mmol·L-1(参考值:132~146mmol·L-1),氯化物107mmol·L-1(参考值:99~109mmol·L-1)。

【辅助检查】

心电图及胸部X线正位平片均正常。5)影像学检查:①头颅MRI平扫+增强(图1):右侧额颞叶及胼胝体区弥散分布血管畸形网,病灶内见迂曲扩张毛细血管网;不同于典型脑动静脉畸形,该病灶畸形血管间混有正常脑实质。②头颅MRA及MRV(图1):右侧额颞叶异常血管网及多支粗大供血动脉及引流静脉,右侧大脑中动脉M1段局部狭窄。③全脑血管造影术(DSA)显示右侧大脑半球弥漫性增殖性血管异常,病灶弥漫分布,供血动脉累及右侧大脑前动脉(ACA)、右侧大脑中动脉(MCA),右侧大脑后动脉(PCA);不同于典型脑动静脉畸形的血管造影表现,该病灶供血动脉及引流静脉间有扩张增生的异常毛细血管网联系,符合CPA的血管造影表现(图2)。④99mTc-ECDSPECT脑血流灌注检查(图3)提示右侧额顶叶血流灌注减低(伴有局部血流灌注缺损)。⑤头颅MR灌注(图4)提示右侧额叶、基底节区、颞叶、枕叶脑血容量(cerebralbloodvolume,CBV)、脑血流量(cerebralbloodflow,CBF)较对侧明显增加,平均通过时间(meantransittime,MTT)及达峰时间(timetopeak,TTP)较对侧略延长,在异常血管网密集的区域CBF、CBV的增加尤为明显。


图1  病例1(2015年11月)头颅MRI(T2WI、增强、MRA和MRV)注:A为T2加权;B为增强序列显示右侧额颞叶多发异常血管网流空信号,异常血管网可不均匀强化;C为头颅MRA;D为头颅MRV 示异常血管网粗大供血动脉及引流静脉
 
图2  病例1(2015年11月)DSA示右侧额颞叶CPA。注:CPA= 增殖型脑血管病(cerebral proliferative angiopathy);A1和2右侧颈内动脉;B1和2左侧颈内动脉;C1和2右侧椎动脉;D1和2右侧颈外动脉
 
图3  病例1 99mTc-ECD SPECT脑血流灌注显像。注:A1~A4(2015年11月术前)提示右侧额顶叶血流灌注减低(局部血流灌注缺损);B1~B4(2016年5月术后随访)提示右侧额顶叶血流灌注较术前明显改善
 
图4  病例1 头颅MR灌注(2015年11月)。注:A为脑血流量;B为脑血容量;C 为平均通过时间;D为达峰时间

【治疗】

常规术前检查及准备后行右侧脑-硬脑膜-颞肌-血管融合术(encephalo-duro-myo-synangiosis,EDMS),见图6。①术中全身麻醉插管后,平卧,头部左偏60°;②采用右侧扩大改良翼点+左侧冠状联合入路,自颞浅深筋膜间分离皮瓣,之后分离颞肌,最后形成右侧额颞骨窗+左侧额部骨窗,另保留上矢状窦处骨桥;③保护好脑膜中动脉,并以其为界扇形剪开硬膜,硬膜悬吊后剪开硬膜,剪开后即见皮质表面异常粗大迂曲血管;④将硬膜表面止血后向下翻转入骨窗外缘,颞肌及骨膜严格止血贴敷于脑表面;⑤回纳骨瓣并逐层缝合皮瓣。术后常规对症支持治疗,患儿围手术期内恢复良好,无并发症。术后随访:术后随访期间患儿恢复良好,未再有短暂性脑缺血(transientischemicattack,TIA)症状发作,双上肢肌力基本对称。术后6个月复查,DSA显示双侧颈外动脉向颅内生长新生小血管,且来自颈外动脉的重建血流向颅内代偿良好,新生血管向颅内代偿良好的部位畸形血管网亦减少甚至消失(图7)。同时复查SPECT提示右侧额顶叶血流灌注较术前明显改善(图3),而复查PWI显示局部畸形血管网范围及血流量均较术前明显下降(图5)。


图5  病例1 区域动脉自旋标记MR灌注显像研究。注:利用t-ASL(区域动脉自旋标记)标记患儿不同血管脑内血流灌注情况:A1、2示术前(2015年11月)患者右侧颈内动脉灌注区域,可见局部血管畸形网内血流信号增高;B1、2示术后随访(2016年5月)右侧颈内动脉灌注区域,可见局部血管畸形网内血流量及范围均较术前明显下降;C1、2示术后随访(2016年5月)右侧颈外动脉血管融合术后脑灌注区域,其右侧额顶叶血流灌注信号明显增加


图6  脑-硬脑膜-颞肌-血管融合术中图片。注:A为采用右侧扩大改良翼点+左侧冠状入路,保留上失状窦处骨桥;B为剪开硬膜后即见皮质表面异常粗大迂曲血管;C、D为将硬膜向下翻转入骨窗外缘,颞肌及骨膜贴敷于脑表面


图7  病例1术后随访全脑血管造影术(2016年5月)注:随访血管造影显示右侧CPA术后,颈外动脉向颅内代偿良好(A1、2),右侧大脑中动脉、前动脉区域的血管增殖范围较术前明显减少(B1、2左侧颈外动脉,C1、2右侧颈内动脉;D1、2右侧颈外动脉)

例2

【一般资料】

患者住院号9103××××,女性,17岁,安徽省人。

【现病史】

患者因“偶发一过性头痛、头晕1年余”于2016年1月就诊入我院。患者近1年来偶在疲乏时出现一过性头痛、头晕症状,休息后可缓解。患者平素体健,生活自理,睡眠良好,胃纳可,大小便正常。

【体格检查】

入院时患者一般情况良好,发育正常,营养状况良好,查体配合,对答切题;双侧瞳孔等大等圆,直径3mm,对光反应灵敏;伸舌居中,吞咽反射良好;四肢肌力可、肌张力正常,腱反射(+),双侧Babinski征(-)、Hoffmann征(-)。

【辅助检查】

①血常规示白细胞计数6.66×109/L,红细胞计数4.78×1012/L,血红蛋白151g·L-1,血小板计数:190×109/L;②空腹血糖示葡萄糖4.2mmol·L-1;③血电解质示钾3.9mmol·L-1,钠142mmol·L-1,氯化物102mmol·L-1;③肾功能示肌酐63μmol·L-1;④肝功能示丙氨酸转氨酶50U·L-1,天冬氨酸转氨酶29U·L-1。4)影像学检查:①头颅CT平扫、头颅MRI平扫+增强显示右侧额颞叶弥漫分布异常血管网(图8);②全脑血管造影术显示右侧额叶、颞叶弥漫性增殖性血管异常,符合CPA的血管造影表现(图8);③99mTc-ECDSPECT脑血流灌注检查提示右侧额叶血流灌注减低(局部血流灌注缺损),见图9;④头颅MR灌注(动脉自旋标记/ASL)提示右侧额叶局部病变组织内CBF较对侧明显增加(图9)。


图8  病例2 头颅CT、MRI和DSA图像注:A为头颅CT平扫;B1为T1加权;B2为T2加权;C为增强序列示右侧额颞叶多发异常血管网信号;D1~4:DSA显示右侧额叶、颞叶弥漫性增殖性血管异常,符合CPA的血管造影表现
 
图9  病例2 99mTc-ECD SPECT脑血流灌注显像及动脉自旋标记MR 灌注显像注:A1、2为99mTc-ECD SPECT 脑血流灌注检查提示右侧额顶叶血流灌注减低(局部血流灌注缺损);B1、2为MRI 动脉自旋标记(ASL)脑血流灌注提示右侧额叶局部病变组织内脑血流量CBF较对侧明显增加

【治疗】

因患者症状轻,日常生活未受明显影响,患者要求保守治疗,故给予患者对症支持治疗并且门诊密切随访。在近9个月的随访过程中,患者症状未见再次发作。

原始出处:

李京润,高超,周茜,高心逸,刘兴党,徐斌.缺血性增殖型脑血管病2例报道及回顾性分析[J].中国临床神经科学,2017,25(1):39-48.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1644673, encodeId=c36b16446e334, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Thu Aug 09 11:21:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893052, encodeId=f50a18930527a, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sat Sep 22 01:21:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316581, encodeId=cf05316581f8, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5nmIH5IQqCKjJgSCuicPWUWOUcdqt1ROPnEiaOYN4pSHibDv8la3OxNLalvuvUXn8clpJlrpuyTpckgt9OPkeSSdT/0, createdBy=8fd71930726, createdName=半夏微凉, createdTime=Sat May 19 09:28:43 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314192, encodeId=a0d5314192dd, content=很好.积极学习临床病例报道, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri May 11 18:52:16 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516773, encodeId=613b1516e738e, content=<a href='/topic/show?id=67e940555fb' target=_blank style='color:#2F92EE;'>#回顾性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40555, encryptionId=67e940555fb, topicName=回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d6111012350, createdName=小小小向日葵, createdTime=Fri May 11 07:21:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313520, encodeId=8369313520a4, content=好文.值得点赞!认真学习了.把经验应用于实践.为患者解除病痛., beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRuUXgacXpPeW0x8Z3Qr9c3I2kTic4ZIpR29iaftYgkjRcbv982icYMtqANBPYBgPnOia6mVtX76qMXuc/0, createdBy=d85d1636106, createdName=lietome2, createdTime=Wed May 09 16:57:09 CST 2018, time=2018-05-09, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1644673, encodeId=c36b16446e334, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Thu Aug 09 11:21:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893052, encodeId=f50a18930527a, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sat Sep 22 01:21:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316581, encodeId=cf05316581f8, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5nmIH5IQqCKjJgSCuicPWUWOUcdqt1ROPnEiaOYN4pSHibDv8la3OxNLalvuvUXn8clpJlrpuyTpckgt9OPkeSSdT/0, createdBy=8fd71930726, createdName=半夏微凉, createdTime=Sat May 19 09:28:43 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314192, encodeId=a0d5314192dd, content=很好.积极学习临床病例报道, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri May 11 18:52:16 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516773, encodeId=613b1516e738e, content=<a href='/topic/show?id=67e940555fb' target=_blank style='color:#2F92EE;'>#回顾性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40555, encryptionId=67e940555fb, topicName=回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d6111012350, createdName=小小小向日葵, createdTime=Fri May 11 07:21:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313520, encodeId=8369313520a4, content=好文.值得点赞!认真学习了.把经验应用于实践.为患者解除病痛., beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRuUXgacXpPeW0x8Z3Qr9c3I2kTic4ZIpR29iaftYgkjRcbv982icYMtqANBPYBgPnOia6mVtX76qMXuc/0, createdBy=d85d1636106, createdName=lietome2, createdTime=Wed May 09 16:57:09 CST 2018, time=2018-05-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1644673, encodeId=c36b16446e334, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Thu Aug 09 11:21:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893052, encodeId=f50a18930527a, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sat Sep 22 01:21:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316581, encodeId=cf05316581f8, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5nmIH5IQqCKjJgSCuicPWUWOUcdqt1ROPnEiaOYN4pSHibDv8la3OxNLalvuvUXn8clpJlrpuyTpckgt9OPkeSSdT/0, createdBy=8fd71930726, createdName=半夏微凉, createdTime=Sat May 19 09:28:43 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314192, encodeId=a0d5314192dd, content=很好.积极学习临床病例报道, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri May 11 18:52:16 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516773, encodeId=613b1516e738e, content=<a href='/topic/show?id=67e940555fb' target=_blank style='color:#2F92EE;'>#回顾性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40555, encryptionId=67e940555fb, topicName=回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d6111012350, createdName=小小小向日葵, createdTime=Fri May 11 07:21:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313520, encodeId=8369313520a4, content=好文.值得点赞!认真学习了.把经验应用于实践.为患者解除病痛., beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRuUXgacXpPeW0x8Z3Qr9c3I2kTic4ZIpR29iaftYgkjRcbv982icYMtqANBPYBgPnOia6mVtX76qMXuc/0, createdBy=d85d1636106, createdName=lietome2, createdTime=Wed May 09 16:57:09 CST 2018, time=2018-05-09, status=1, ipAttribution=)]
    2018-05-19 半夏微凉

    学习了谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1644673, encodeId=c36b16446e334, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Thu Aug 09 11:21:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893052, encodeId=f50a18930527a, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sat Sep 22 01:21:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316581, encodeId=cf05316581f8, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5nmIH5IQqCKjJgSCuicPWUWOUcdqt1ROPnEiaOYN4pSHibDv8la3OxNLalvuvUXn8clpJlrpuyTpckgt9OPkeSSdT/0, createdBy=8fd71930726, createdName=半夏微凉, createdTime=Sat May 19 09:28:43 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314192, encodeId=a0d5314192dd, content=很好.积极学习临床病例报道, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri May 11 18:52:16 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516773, encodeId=613b1516e738e, content=<a href='/topic/show?id=67e940555fb' target=_blank style='color:#2F92EE;'>#回顾性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40555, encryptionId=67e940555fb, topicName=回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d6111012350, createdName=小小小向日葵, createdTime=Fri May 11 07:21:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313520, encodeId=8369313520a4, content=好文.值得点赞!认真学习了.把经验应用于实践.为患者解除病痛., beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRuUXgacXpPeW0x8Z3Qr9c3I2kTic4ZIpR29iaftYgkjRcbv982icYMtqANBPYBgPnOia6mVtX76qMXuc/0, createdBy=d85d1636106, createdName=lietome2, createdTime=Wed May 09 16:57:09 CST 2018, time=2018-05-09, status=1, ipAttribution=)]
    2018-05-11 虈亣靌

    很好.积极学习临床病例报道

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1644673, encodeId=c36b16446e334, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Thu Aug 09 11:21:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893052, encodeId=f50a18930527a, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sat Sep 22 01:21:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316581, encodeId=cf05316581f8, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5nmIH5IQqCKjJgSCuicPWUWOUcdqt1ROPnEiaOYN4pSHibDv8la3OxNLalvuvUXn8clpJlrpuyTpckgt9OPkeSSdT/0, createdBy=8fd71930726, createdName=半夏微凉, createdTime=Sat May 19 09:28:43 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314192, encodeId=a0d5314192dd, content=很好.积极学习临床病例报道, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri May 11 18:52:16 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516773, encodeId=613b1516e738e, content=<a href='/topic/show?id=67e940555fb' target=_blank style='color:#2F92EE;'>#回顾性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40555, encryptionId=67e940555fb, topicName=回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d6111012350, createdName=小小小向日葵, createdTime=Fri May 11 07:21:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313520, encodeId=8369313520a4, content=好文.值得点赞!认真学习了.把经验应用于实践.为患者解除病痛., beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRuUXgacXpPeW0x8Z3Qr9c3I2kTic4ZIpR29iaftYgkjRcbv982icYMtqANBPYBgPnOia6mVtX76qMXuc/0, createdBy=d85d1636106, createdName=lietome2, createdTime=Wed May 09 16:57:09 CST 2018, time=2018-05-09, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1644673, encodeId=c36b16446e334, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Thu Aug 09 11:21:00 CST 2018, time=2018-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893052, encodeId=f50a18930527a, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Sat Sep 22 01:21:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=316581, encodeId=cf05316581f8, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5nmIH5IQqCKjJgSCuicPWUWOUcdqt1ROPnEiaOYN4pSHibDv8la3OxNLalvuvUXn8clpJlrpuyTpckgt9OPkeSSdT/0, createdBy=8fd71930726, createdName=半夏微凉, createdTime=Sat May 19 09:28:43 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314192, encodeId=a0d5314192dd, content=很好.积极学习临床病例报道, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri May 11 18:52:16 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516773, encodeId=613b1516e738e, content=<a href='/topic/show?id=67e940555fb' target=_blank style='color:#2F92EE;'>#回顾性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40555, encryptionId=67e940555fb, topicName=回顾性分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d6111012350, createdName=小小小向日葵, createdTime=Fri May 11 07:21:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313520, encodeId=8369313520a4, content=好文.值得点赞!认真学习了.把经验应用于实践.为患者解除病痛., beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRuUXgacXpPeW0x8Z3Qr9c3I2kTic4ZIpR29iaftYgkjRcbv982icYMtqANBPYBgPnOia6mVtX76qMXuc/0, createdBy=d85d1636106, createdName=lietome2, createdTime=Wed May 09 16:57:09 CST 2018, time=2018-05-09, status=1, ipAttribution=)]
    2018-05-09 lietome2

    好文.值得点赞!认真学习了.把经验应用于实践.为患者解除病痛.

    0

相关资讯

Neurology:颈动脉支架置入后三甲胺N-氧化物升高与缺血性脑损伤有关!

由此可见,TMAO水平升高与CAS后MRI扫描中新发缺血性脑损伤风险增加有关。

Stroke:缺血性卒中患者30天再入院的估计!

高达12%的缺血性脑卒中患者在出院30天内再次入院,再通治疗与30天再住院的几率降低11%到23%有关。

Stroke:急性缺血性脑卒中血管内治疗后症状性颅内出血的预测因素分析!

在亚洲急性缺血性脑卒中患者中取栓后SICH的发生率较高。心源性卒中、侧支循环较差、延迟介入治疗、支架取栓装置多次通过、较低的预处理阿尔伯塔卒中计划早期CT评分、较高的基础中性粒细胞比率可能增加发生SICH的风险。

JACC:在缺血性和非缺血性心衰患者中,T2DM都可以预测死亡

心衰(HF)是2型糖尿病(T2DM)患者常见和严重的并发症。然而,此类患者的缺血性HF和血管重建的预后还没有很好地被调查。该研究的目的是在一个有和没有T2DM的患者群中,调查缺血性与非缺血HF和以前血运重建对该患者群的长期预后影响。在瑞典心衰注册(SwedeHF)中,研究人员通过糖尿病状态和缺血性或非缺血性HF,以及血运重建史对患者进行分层,研究人员在2003年至2011年期间对这些患者进行了随访

欧洲研究:近1/4慢性缺血性心血管病患者半年内死亡或住院

一项发表在Eur J Prev Cardiol上的研究显示,近25%的慢性缺血性心血管疾病患者在半年内死亡或住院。

JACC:替卡格雷可降低外周动脉疾病患者(曾患过心梗)的缺血性风险

在之前有过心肌梗死(MI)的患者中,外周动脉疾病(PAD)与缺血性和出血风险增加有关。这项研究评估了在PAD和之前有过MI的患者中,替卡格雷治疗对于主要心血管(CV)事件和重大不良肢体事件的疗效性和安全性。PEGASUS-TIMI54研究随机分配21162例之前有过MI(1〜3年)的患者接受替卡格雷90毫克每天两次,替卡格雷60毫克,每天两次,或安慰剂,所有都以低剂量阿司匹林为背景。是否有PAD的